Ignite Creation Date:
2025-12-25 @ 12:41 AM
Ignite Modification Date:
2026-02-28 @ 2:49 AM
Study NCT ID:
NCT02781467
Status:
TERMINATED
Last Update Posted:
2020-07-22
First Post:
2016-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML)
Sponsor:
Celularity Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-11
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-07
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-20
First Submit QC Date:
None
Study First Post Date:
2016-05-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-20
Last Update Post Date:
2020-07-22
Last Update Post Date Type:
ACTUAL